Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

The protocol presented here provides a step-by-step approach for the isolation of cardiac resident macrophages from the sinoatrial node (SAN) and atrioventricular node (AVN) region of mouse hearts.

Abstract

Resident cardiac macrophages have been demonstrated to facilitate the electrical conduction in the heart. The physiologic heart rhythm is initiated by electrical impulses generated in sinoatrial node (SAN) and then conducted to ventricles via atrioventricular node (AVN). To further study the role of resident macrophages in cardiac conduction system, a proper isolation of resident macrophages from SAN and AVN is necessary, but it remains challenging. Here, we provide a protocol for the reliable microdissection of the SAN and AVN in murine hearts followed by the isolation and culture of resident macrophages.

Both, SAN which is located at the junction of the crista terminalis with the superior vena cava, and AVN which is located at the apex of the triangle of Koch, are identified and microdissected. Correct location is confirmed by histologic analysis of the tissue performed with Masson's trichrome stain and by anti-HCN4.

Microdissected tissues are then enzymatically digested to obtain single cell suspensions followed by the incubation with a specific panel of antibodies directed against cell-type specific surface markers. This allows to identify, count, or isolate different cell populations by fluorescent activated cell sorting. To differentiate cardiac resident macrophages from other immune cells in the myocardium, especially recruited monocyte-derived macrophages, a delicate devised gating strategy is needed. First, lymphoid lineage cells are detected and excluded from further analysis. Then, myeloid cells are identified with resident macrophages being determined by high expression of both CD45 and CD11b, and low expression of Ly6C. With cell sorting, isolated cardiac macrophages can then be cultivated in vitro over several days for further investigation. We, therefore, describe a protocol to isolate cardiac resident macrophages located within the cardiac conduction system. We discuss pitfalls in microdissecting and digesting SAN and AVN, and provide a gating strategy to reliably identify, count and sort cardiac macrophages by fluorescence-activated cell sorting.

Introduction

The sinoatrial node (SAN) physiologically initiates the electrical impulse and is, therefore, the primary pacemaker of the heart. The atrioventricular node (AVN) conducts the electrical impulse from the atria to the ventricles and also acts as a subsidiary pacemaker1. In general, generation and conduction of electrical impulses is a complex process that can be modulated by various factors2, including resident macrophage in SAN/AVN regions. A recent study by Hulsmans et al. demonstrates a specific population of cardiac resident macrophages which are enriched in the AVN and function as key players in keeping a steady heartbeat3. They found that macrophages are electrically coupled to the cardiomyocytes and could change the electrical properties of coupled cardiomyocytes. The authors also note that such conducting cells interleaving with macrophages are also present in other components of the cardiac conduction system, such as the SAN.

Currently, it is not fully known if the phenotype of resident cardiac macrophages differs between the cardiac regions. However, it has been shown that the tissue microenvironment can affect transcription and proliferative renewal of tissue macrophages4. Furthermore, since the cardiomyocyte phenotype has been demonstrated to be different between regions, the functional effects of macrophages on cardiomyocytes may also be region-specific, even if the macrophage phenotype itself may be the same. Therefore, further studies on specific cardiac regions are needed.

Recent studies have demonstrated that, at steady state, the tissue resident macrophages are established prenatally, arising independently of definitive hematopoiesis, and persist into adulthood5. However, after macrophage depletion or during cardiac inflammation, Ly6chi monocytes contribute to replenish cardiac macrophage population6. Studies involving genetic lineage tracing, parabiosis, fate mapping, and cell tracking showed the coexistence of a variety of tissue resident macrophages populations in organs and tissues, and, also, different cellular behavior of macrophage subsets that are potentially associated with their ontogeny7,8,9.

Characterization of resident cardiac macrophages has benefited from the use of magnetic activated cell sorting (MACS) and fluorescent activated cell sorting. These methods are particularly useful for isolating specific cell populations from multiple tissue fractions by labeling them with their cell surface markers. This not only leads to a higher purity of the isolated immune cell type, but also allows for phenotypic analysis. Here, we present a protocol including magnetic beads-coated cells followed with fluorescent activated cell sorting for the enrichment of cardiac resident macrophages specifically isolated from the SAN and AVN region.

To explore the characteristics of cardiac resident macrophages in conduction system and their function for cardiac conduction and arrhythmogenesis, precise localization and dissection of SAN and AVN are critical. For microdissection of SAN and AVN, anatomical landmarks are used for the region identification10. In brief, SAN is located at the junction of the superior vena cava and right atrium. AVN is located within the triangle of Koch, which is anteriorly bordered by the septal leaflet of the tricuspid valve, and posteriorly by the tendon of Todaro11. We also provide an accurate microdissection procedure of SAN and AVN in mice which is confirmed by histology and immunofluorescence staining.

Isolated resident macrophages could be used for further experiments such as RNA sequencing or could be recovered and cultivated for more than two weeks allowing various in vitro experiments. Therefore, our protocol describes a highly valuable procedure for the immuno-rhythmologist. Table 1 shows the composition of all the solutions needed, Figure 1 shows the microdissection landmarks for SAN and AVN. Figure 2 is schematic illustration of SAN and AVN localization. Figure 3 shows the histological staining of SAN and AVN (Masson's trichrome and immunofluorescence staining). Figure 4 shows a step-by-step gating strategy to isolate cardiac resident macrophages by fluorescence-activated cell sorting.

Protocol

Animal care and all experimental procedures were conducted in accordance with the guidelines of the Animal Care and Ethics committee of the University of Munich and all the procedures undertaken on mice were approved by the Government of Bavaria, Munich, Germany. C57BL6/J mice were commercially obtained.

1. Preparations

  1. Prepare Cell sorting buffer (Table 1) and store at 4 °C.
    NOTE: During the whole experimental procedure, the cell sorting buffer should always be on ice.
  2. Prepare Digestion buffer (Table 1) shortly before the digestion as the activity of collagenase could only be detected for few hours at room temperature.
  3. Refer to the previously published protocol for the preparation of dissection dish10. In brief, add 30 mL of agarose gel (3%-4%) into a 100 mm diameter Petri dish and cool down at room temperature.

2. Animal sacrifice and heart excision

  1. Anesthetize the mouse with isoflurane by placing it into an incubation chamber connected with an isoflurane vaporizer and flushed with 5% isoflurane/95% oxygen.
  2. After the injection of fentanyl for analgesia, open the rib cage and perfuse the heart by injecting 5-10 mL of ice-cold 1x PBS directly into the left ventricle (LV). Extract the mice heart and put it on the dissection dish. Experimental details have been described in detail previously10.

3. Microdissection of SAN and AVN

  1. After isolating the heart, perform the following microdissection procedures in the dissection dish with ice-cold 1x PBS under the dissecting microscope.
  2. Use the cardiac anatomical landmarks, i.e., aorta, pulmonary artery, coronary sinus, left/right ventricle, etc. to determine the left/right (left: LV; right: RV) and anterior/posterior (anterior: aorta; posterior: coronary sinus) of the heart. After the orientation is determined, turn around the heart with the front of it at the bottom of the dish (to expose the large veins that are located posterior).
  3. Microdissection of SAN
    NOTE: Microdissection of the SAN have been previously described10. The process is described in brief below.
    1. Expose the inter-caval region by pining the right atrial appendages (RAA) and the tissue adjacent to superior vena cava (SVC) and inferior vena cava (IVC) on the microdissection dish using insect pins.
    2. Cut the heart along the interatrial septum parallel to the crista terminalis (CT) to separate the inter-caval region and to obtain the SAN sample (Figure 1A, Figure 2A). Put the sample in an empty 1.5 mL microcentrifuge tube on ice.
  4. Microdissection of AVN
    1. After collection of the SAN sample ensure that the RAA and parts of the right atrium (RA) have already been cut away leaving only the interatrial septum (IAS) and, interventricular septum (IVS).
    2. Pin the remaining parts of the heart through the tissue adjacent to the IAS and IVS using insect pins to make the right atrial side of IAS facing up.
    3. Look at the right atrium on the endocardial surface for the triangle of Koch. It will be bordered anteriorly by the hinge-line of the septal leaflet of the tricuspid valve (TV), and posteriorly by the tendon of Todaro. The orifice of the coronary sinus is observed at the base. (Figure 1B, Figure 2B).
    4. Cut the triangle of Koch, which contains the AVN, and directly put it in an empty 1.5 mL microcentrifuge tube on ice.

4. Digestion

  1. Prepare the Digestion buffer (Table 1) shortly before use.
  2. Mince the SAN and AVN tissue well with scalpels.
    NOTE: Mincing the tissue well will increase the digestion efficiency and help to get good cell suspension for sorting. As the SAN and AVN samples are quite small, mincing the tissue directly inside the 1.5 mL microcentrifuge tube is recommended to reduce the loss of sample.
  3. Add 500 µL of digestion buffer per sample and wash down all minced tissue from the wall of the 1.5 mL microcentrifuge tube. Gentle pipetting helps digesting the sample.
  4. Homogenize the tube on a vortex machine (settings: 37 °C, 750 rpm for 1 h).
  5. After digestion, transfer the tissue suspension to a fresh 15 mL centrifuge tube by passing through a 40 µm cell strainer. Rinse the cell strainer with an additional 5 mL of cell sorting buffer to stop the digestion.
  6. Centrifuge the 15 mL tube at 350 x g for 7 min at 4 °C. Then remove the supernatant completely using the pipette. Resuspend the cell pellet with 90 µL cell sorting buffer.
    ​NOTE: Before magnetic separation, pipette the cell suspension gently a few times or pass through a 30 µm cell strainer to remove cell clumps if necessary, to obtain a single cell suspension for optimal performance of magnetic enrichment of interesting cell populations.

5. Magnetic enrichment of CD45 and sample staining

NOTE: To isolate the cardiac macrophages with high sorting efficiency, exclusion of undesired cells including lymphocytes was performed with CD45 microbeads according to the manufacturer's protocol. Based on the sorting panel, cardiac resident macrophages were identified as CD45highCD11bhighCD64high Ly6Clow/int F4/80high.

  1. Add 10 µL of CD45 microbeads per 107 total cells to the cell suspension in the 15 mL centrifuge tube. Mix the samples well and incubate them for 15 min at 4 °C.
    NOTE: The cell counting using a hemocytometer should be briefly done to make sure that each tube contains no more than 107 total cells. When working with higher cell numbers, the volume of magnetic beads needs to be scaled up.
  2. Prepare the antibody mixture by diluting the following antibodies in cell sorting buffer (1:100 dilution for each antibody): CD45-PE, CD11b-APC-Cy7, CD64-APC, F4/80-PE-Cy7, Ly6C-FITC. DAPI will be added later to the staining for live/dead discrimination.
  3. After 15 min of magnetic bead incubation, add 100 µL of antibody mixture directly into the cell suspension in the 15 mL tube (then all the antibodies' final concentration is 1:200) and incubate for 20 min at 4 °C.
  4. After 20 min of antibody incubation, wash the cell suspension by adding 1-2 mL of cell sorting buffer per 107 cells and centrifuge at 350 x g for 10 min. Completely remove the supernatant by pipetting.
  5. Resuspend up to 108 cells in 500 µL of cell sorting buffer.
    NOTE: The maximum cell number for magnetic separation should be determined according to the manufacturer's protocol.
  6. Prepare the magnetic separation set.
    1. Attach the magnetic column to a suitable magnetic separator and place a collection tube under the magnetic column.
    2. Prepare the magnetic columns by rinsing with cell sorting buffer: add 500 µL of cell sorting buffer at the top of the column and let the buffer pass through.
  7. Apply the cell suspension immediately onto the column while the cell sorting buffer is passing through.
    NOTE: Avoid the formation of air bubbles in the column. As per the manufacture's protocol, although the column filling time might change from storage conditions, it has no influence on the quality of the separation.
  8. Wash the column with 3 x 500 µL cell sorting buffer. The flow-through in step 5.7 and step 5.8 contain unlabeled cells, which can be discarded if no further experiment is needed.
    ​NOTE: Add the cell sorting buffer immediately when the column reservoir is nearly empty.
  9. Remove the column from the magnetic separator and place it on a new collection tube.
  10. Add 1 mL of cell sorting buffer onto the column. Immediately flush the column by firmly applying the plunger supplied with the column. The flow-through contains the magnetically labeled cells.
  11. Add DAPI solution into all the collected magnetically labeled cell suspensions shortly before running them on the cell sorter. Adjust the final concentration of DAPI to 0.3-0.5 µg/mL.
  12. Perform FACS analysis.

6. Samples for compensation

  1. Prepare 6 brown 1.5 mL microcentrifuge tubes labeled as "PE", "APC-Cy7", "APC", "PE-Cy7", "FITC", and "DAPI" respectively to protect antibodies from light. Prepare one more 1.5 mL microcentrifuge tube labeled as "unstained".
    NOTE: This could be done at the same time as incubating the cell suspension with the microbeads and antibodies. The unstained sample could be the cardiomyocyte tissue collected randomly from the spared heart tissue and also treated according to step 4.
  2. Dilute each single fluorescence-conjugated antibody with cell sorting buffer into 1:50 in the 1.5 mL brown microcentrifuge tubes that are marked accordingly.
  3. Add one drop of compensation beads solution and incubate for 20 min at 4 °C.
  4. Add 2 mL of cell sorting buffer into each 1.5 mL brown microcentrifuge tube and centrifuge at 450 x g for 5 min. Completely discard the supernatant and resuspend the bead containing pellet with 300 µL cell sorting buffer and transfer them into cell sorter tubes that are also marked accordingly.

7. Running on the cell sorter and gating strategy

  1. Apply the unstained sample and compensation tubes first and adjust the voltages of each channel to align both the positive and negative peak to the proper position of the axis. Save the compensation settings and apply it to the following samples.
  2. Apply the samples on the cell sorter. Set the gating strategy as described in Figure 4. Cardiac resident macrophages are identified as CD45highCD11bhighCD64highLy6Clow/int F4/80high. DAPI is used as a cell viability marker.
  3. Check the flow cytometry charts to confirm that the cell population of interest is properly shown on the charts. If not, adjust the voltage of each channel to the center view of each chart.
  4. If the voltage settings are satisfactory, start the sorting procedure. Collect the sorted cell population into culture medium composed of DMEM containing 10% fetal bovine serum, supplemented with 100 µg/mL streptomycin and 100 U/mL penicillin.

8. Resident macrophages culture

  1. After gathering the sorted macrophages, transfer the cells immediately either to 35 mm tissue culture dishes or 24 well plate, or directly use them for subsequent experiments.
  2. To culture sorted macrophages, incubate the cells at 37 °C, 5% CO2 incubator.
  3. Change the culture medium every 48-72 h. Floating dead cells can be easily removed by medium change. Use live macrophages attaching to the bottom of culture dish for subsequent experiment.

Results

We describe a practical procedure for the isolation of cardiac resident macrophages specifically from the SAN and AVN region. To confirm a correct dissection, Masson's Trichrome staining and immunofluorescent HCN4-staining is performed (Figure 3)12. With this protocol, we could collect approximately 60,000 macrophages from one whole heart. Figure 4 shows the gating strategy for sorting cardiac macrophages. Live resident cardiac macrop...

Discussion

In this manuscript, we describe a protocol for the enrichment of cardiac resident macrophages specifically from the SAN and AVN regions at high purity.

Macrophages are divided into subpopulations based on their anatomical location and functional phenotype. They can also switch from one functional phenotype to another in response to variable microenvironmental signals13. Compared to other organs such as bone marrow and liver, cardiac tissue contains a lower percentage of...

Disclosures

No potential conflict of interest relevant to this article was reported.

Acknowledgements

This work was supported by the China Scholarship Council (CSC, to R. Xia), the German Centre for Cardiovascular Research (DZHK; 81X2600255 to S. Clauss, 81Z0600206 to S. Kääb, 81Z0600204 to C.S.), the Corona Foundation (S199/10079/2019 to S. Clauss), the SFB 914 (project Z01 to S. Massberg), the ERA-NET on Cardiovascular Diseases (ERA-CVD; 01KL1910 to S. Clauss) and the Heinrich-and-Lotte-Mühlfenzl Stiftung (to S. Clauss). The funders had no role in manuscript preparation.

Materials

NameCompanyCatalog NumberComments
Anesthesia
Isoflurane vaporizer systemHugo Sachs Elektronik34-0458, 34-1030, 73-4911, 34-0415, 73-4910Includes an induction chamber, a gas evacuation unit and charcoal filters
Modified Bain circuitHugo Sachs Elektronik73-4860Includes an anesthesia mask for mice
Surgical PlatformKent scientificSURGI-M
In vivo instrumentation
Fine forcepsFine Science Tools11295-51
Iris scissorsFine Science Tools14084-08
Spring scissorsFine Science Tools91500-09
Tissue forcepsFine Science Tools11051-10
Tissue pinsFine Science Tools26007-01Could use 27G needles as a substitute
General lab instruments
Orbital shakerSunlabD-8040
Pipette,volume 10ul, 100ul, 1000ulEppendorfZ683884-1EA
Magnetic stirrerIKARH basic
Microscopes
Dissection stereo- zoom microscopevwr10836-004
Leica microscopeLeica microsystemsLeica DM6
Flow cytometry machine
Beckman CoulterBeckman coulterMoFlo Astrios
Software
FlowJo v10FlowJo
General Lab Material
0.2 µm syringe filtersartorius17597
100 mm petri dishFalcon351029
27G needleBD Microlance 3300635
50 ml Polypropylene conical TubeFALCON352070
Cover slipsThermo scientific7632160
Eppendorf TubesEppendorf30121872
5ml SyringeBraun4606108V
Chemicals
0.5 M EDTASigma20-158
Acetic acidMerck100063Component of TEA
AgaroseBiozym850070
Bovine Serum AlbuminSigmaA2153-100G
Collagenase IWorthington BiochemicalLS004196
Collagenase XISigmaC7657
DNase ISigmaD4527
HyaluronidaseSigmaH3506
HEPES bufferSigmaH4034
Bovine Serum AlbuminSigmaA2153-100G
DPBS (1X) Dulbecco's Phosphate Buffered SalineGibco14190-094
Fetal bovine serumSigmaF2442-500ml
Penicillin − StreptomycinSigmaP4083
DMEMGibco41966029
Drugs
Fentanyl 0.5 mg/10 mlBraun Melsungen
Isoflurane 1 ml/mlCp-pharma31303
Oxygen 5LLinde2020175Includes a pressure regulator
Antibodies
Anti-mouse Ly6C FITC (clone HK1.4)BioLegendCat# 128006diluted to 1:100
Anti-mouse F4/80 PE/Cy7(clone BM8)BioLegendCat# 123114diluted to 1:100
Anti-mouse CD64 APC (clone X54-5/7.1)BioLegendCat# 139306diluted to 1:100
Anti-mouse CD11b APC/Cy7(clone M1/70)BioLegendCat# 101226diluted to 1:100
Anti-mouse CD45 PE (clone 30-F11)BioLegendCat# 103106diluted to 1:100
Hoechst 33342, Trihydrochloride, Trihydrate (DAPI)InvitrogenH3570diluted to 1:1000
Animals
Mouse, C57BL/6Charles River Laboratories

References

  1. Nikolaidou, T., Aslanidi, O. V., Zhang, H., Efimov, I. R. Structure-function relationship in the sinus and atrioventricular nodes. Pediatric Cardiology. 33 (6), 890-899 (2012).
  2. Clauss, S., et al. Animal models of arrhythmia: classic electrophysiology to genetically modified large animals. Nature Review Cardiology. 16 (8), 457-475 (2019).
  3. Hulsmans, M., et al. Macrophages Facilitate Electrical Conduction in the Heart. Cell. 169 (3), 510-522 (2017).
  4. Rosas, M., et al. The transcription factor Gata6 links tissue macrophage phenotype and proliferative renewal. Science. 344 (6184), 645-648 (2014).
  5. Schulz, C., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 336 (6077), 86-90 (2012).
  6. Epelman, S., et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity. 40 (1), 91-104 (2014).
  7. Gordon, S., Pluddemann, A. Tissue macrophages: heterogeneity and functions. BMC Biology. 15 (1), 53 (2017).
  8. Bajpai, G., et al. The human heart contains distinct macrophage subsets with divergent origins and functions. Nature Medicine. 24 (8), 1234-1245 (2018).
  9. Davies, L. C., Jenkins, S. J., Allen, J. E., Taylor, P. R. Tissue-resident macrophages. Nature Immunology. 14 (10), 986-995 (2013).
  10. Xia, R., et al. Whole-mount immunofluorescence staining, confocal imaging and 3D reconstruction of the sinoatrial and atrioventricular node in the mouse. Journal of Visualized Experiments. (166), e62058 (2020).
  11. van Weerd, J. H., Christoffels, V. M. The formation and function of the cardiac conduction system. Development. 143 (2), 197-210 (2016).
  12. Ye Sheng, X., et al. Isolation and characterization of atrioventricular nodal cells from neonate rabbit heart. Circulation: Arrhythmia and Electrophysiology. 4 (6), 936-946 (2011).
  13. Murray, P. J., Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nature Reviews Immunology. 11 (11), 723-737 (2011).
  14. Pinto, A. R., et al. Revisiting cardiac cellular composition. Circulation Research. 118 (3), 400-409 (2016).
  15. Bajpai, G., et al. Tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury. Circulation Research. 124 (2), 263-278 (2019).
  16. Honold, L., Nahrendorf, M. Resident and monocyte-derived macrophages in cardiovascular disease. Circulation Research. 122 (1), 113-127 (2018).
  17. Leid, J., et al. Primitive embryonic macrophages are required for coronary development and maturation. Circulation Research. 118 (10), 1498-1511 (2016).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Cardiac MacrophagesMicrodissectionFluorescence activated Cell SortingSinoatrial NodeAtrioventricular NodeIsolation ProtocolHeart AnatomyCardiac ElectrophysiologyTissue DigestionCardiac Tissue SamplesResident MacrophagesHigh Purity IsolationSurgical Technique

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved